Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|February 28, 1994
Expression of the p53 tumour suppressor gene product is a determinant of chemosensitivityR D Petty, I A Cree, L A Sutherland, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1993
Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assayE M Hunter, L A Sutherland, I A Cree, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer: laboratory study and clinical pilot trialC M Kurbacher, H W Bruckner, I A Cree, et al.
Anti-Cancer Drugs|March 10, 1998
Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancerC M Kurbacher, I A Cree, H W Bruckner, et al.
Anti-Cancer Drugs|August 1, 1996
Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivityI A Cree, C M Kurbacher, M Untch, et al.
Anti-Cancer Drugs|September 7, 1999
Heterogeneity of chemosensitivity of metastatic cutaneous melanomaI A Cree, M H Neale, N E Myatt, et al.
BMC Cancer|August 29, 2009
Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)Sharon Glaysher, Dennis Yiannakis, Francis G Gabriel, et al.
The European Physical Journal. C, Particles and Fields|December 31, 2019
Characterization of 30 <math></math> Ge enriched Broad Energy Ge detectors for GERDA Phase IIM Agostini, A M Bakalyarov, E Andreotti, et al.
Pageof 5